Most cancers begin inside one animal’s own cells. This one is stranger and, frankly, more unsettling: the tumor is contagious. Canine transmissible venereal tumor is a cancer that jumps from dog to dog as living cells, passed along by contact. And yes, that includes the enthusiastic butt-sniffing that is basically a canine handshake.
So here is the part worth leading with, before the queasiness sets in: of all the cancers your dog could face, this is one of the ones you’d actually want to draw. Caught and treated properly, it usually goes away. The horror-movie premise has a genuinely reassuring ending.
A cancer that travels
Picture a friendly two-year-old intact male, freshly off the streets and into a good home. A few weeks in, he’s licking at himself constantly and his breath has turned foul. At the exam, the vet pulls back the sheath and finds a lumpy, ulcerated mass at the base of the penis. The diagnosis is transmissible venereal tumor, and it did not start in him. It moved into him from another dog.
Unlike almost every other tumor, this one spreads by transplanting its own cancer cells directly onto a new dog. Most often that transfer happens during mating, which is why the genitals are the classic site. But the cells will travel on any contact that puts bare tissue against bare tissue. Once they take hold, they grow into a tumor right where the contact happened.
It starts small, a modest bump on the genitals of either sex, and then it moves quickly. The irritation makes the dog lick, the licking irritates more, and you get bleeding, oozing, and a distinctive bad smell. That cycle is often the first thing an owner actually notices.
How it ends up on a dog’s face
The genitals are not the only landing spot. Because dogs greet and investigate each other nose-to-rear, tumor cells can transfer to the nose and mouth, producing what’s called primary oronasal transmissible venereal tumor, tumors in the face with no genital involvement at all.
Researchers at the University of Cambridge dug into who this happens to, using a database built over a decade holding nearly 2,000 TVT cases. When they narrowed it to nose-and-mouth-only tumors, they found just 32, meaning the oronasal form is genuinely rare, only about two percent of cases. But within that small group, the pattern was striking: males were at four-to-five times greater risk than females, and over 80 percent of the facial cases (27 of 32) were male dogs.
The explanation is behavioral and anatomical. Male dogs sniff and lick female genitals to check whether a female is in heat. Female genital tumors also tend to sit more exposed and accessible than male ones, which are tucked inside the prepuce. Put those together, a male preference for investigating females and more reachable tumors on females, and you get males catching the facial form far more often. Oronasal cases can show up as sneezing, nosebleeds, drooling, bad breath, and even tooth loss.
Telling it apart from every other lump
Dogs grow lumps and bumps all the time, and most aren’t this. Diagnosis leans on the dog’s history, a physical exam, and a tissue sample. History does a lot of the work here: dogs allowed to roam, exposed to strays, or used for breeding carry real risk. So does appearance and location, an irregular, ulcerated sore on the genitals has a short list of possible causes. Confirmation comes from a fine-needle aspirate and cytology, or a biopsy. Only once it’s confirmed does a treatment plan get built.
“The word ‘cancer’ understandably makes people brace for the worst, and ‘contagious cancer’ sounds even scarier,” says Dr. Priya Nair. “But this is one of the times I get to walk into the room with genuinely good news. When we catch a transmissible venereal tumor and treat it correctly, most of these dogs are cured. It behaves very differently from the cancers we truly fear.”
The genuinely good news about treatment
TVT is highly treatable and carries an excellent prognosis with proper care. The standard treatment is chemotherapy, specifically weekly injections of vincristine over several weeks, which succeed in shrinking and clearing the tumors in the large majority of dogs. For tumors that don’t respond to chemo, radiation is an effective backup.
Surgery plays a smaller role than you might expect. Because these tumors sit on sensitive, hard-to-operate areas, and getting clean, wide surgical margins there is difficult, surgery is usually reserved for small tumors and is rarely the first choice. Chemotherapy simply works better for this particular cancer.
The practical bottom line: this is not a reason to stop your dog from saying hello to the neighborhood. Greeting other dogs is normal and healthy. It’s a reason to keep intact dogs from roaming and breeding indiscriminately, to steer clear of stray populations, and to get any odd, ulcerated genital or facial lump looked at promptly, because for once, an early “yes, it’s cancer” comes with an unusually happy prognosis.
When to call your vet
Book a visit for any persistent lump on the genitals, especially one that bleeds, oozes, or smells; for constant genital licking; or for unexplained facial signs like chronic nosebleeds, sneezing, drooling, or bad breath in a dog with a history of roaming or breeding. Early evaluation is what turns a scary diagnosis into a routine course of treatment.
What newer research adds
Transmissible venereal tumor is now one of the most studied “transmissible cancers” in biology, because its cell line is ancient, it descends from a single dog that lived thousands of years ago and has been passing between dogs ever since, which makes it a living record of canine history and a model for how cancers evade the immune system. That research matters clinically because it’s helping explain why the tumors eventually regress: the dog’s immune system, sometimes with chemotherapy’s help, learns to recognize the foreign cells. On the ground, the disease remains far more common in regions with large free-roaming and unneutered dog populations and much rarer where spay-neuter and roaming controls are widespread, another concrete argument for those measures. Treatment protocols have stayed remarkably stable because vincristine works so reliably, and prognosis remains excellent, which is why this stays a rare piece of reassuring news in veterinary oncology.
